Molina Healthcare, Inc. (NYSE:MOH) Shares Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets boosted its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 138.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 177,150 shares of the company's stock after buying an additional 102,840 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.31% of Molina Healthcare worth $51,560,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of MOH. Waldron Private Wealth LLC boosted its stake in Molina Healthcare by 4.7% in the fourth quarter. Waldron Private Wealth LLC now owns 729 shares of the company's stock valued at $212,000 after acquiring an additional 33 shares in the last quarter. Angeles Investment Advisors LLC boosted its position in shares of Molina Healthcare by 5.4% in the 4th quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock valued at $244,000 after purchasing an additional 43 shares during the period. Coldstream Capital Management Inc. grew its stake in Molina Healthcare by 2.1% during the 4th quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock worth $683,000 after buying an additional 48 shares during the last quarter. Lindbrook Capital LLC increased its position in Molina Healthcare by 38.5% during the fourth quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock worth $60,000 after buying an additional 57 shares during the period. Finally, Quadrant Capital Group LLC lifted its stake in Molina Healthcare by 11.4% in the fourth quarter. Quadrant Capital Group LLC now owns 627 shares of the company's stock valued at $182,000 after buying an additional 64 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently commented on MOH. Barclays lifted their target price on shares of Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a report on Friday, April 25th. Truist Financial lifted their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Stephens reiterated an "equal weight" rating and set a $345.00 target price on shares of Molina Healthcare in a research note on Thursday, February 6th. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price target for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Finally, Guggenheim initiated coverage on Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Nine analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $365.38.

Molina Healthcare Price Performance

Molina Healthcare stock traded down $2.02 during mid-day trading on Friday, reaching $323.84. The company had a trading volume of 602,871 shares, compared to its average volume of 682,380. The stock's 50-day simple moving average is $324.73 and its 200-day simple moving average is $308.48. The company has a market capitalization of $17.55 billion, a P/E ratio of 15.85, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Molina Healthcare's revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $5.73 earnings per share. On average, equities analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the transaction, the chief executive officer now directly owns 257,715 shares in the company, valued at approximately $82,484,262.90. This represents a 25.35 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director now owns 11,244 shares of the company's stock, valued at approximately $3,603,702. This trade represents a 5.62 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 89,169 shares of company stock valued at $28,520,995. Insiders own 1.10% of the company's stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.